» Articles » PMID: 20421418

A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction Between Keap1 and P62

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2010 Apr 28
PMID 20421418
Citations 437
Authors
Affiliations
Soon will be listed here.
Abstract

In response to stress, cells can utilize several cellular processes, such as autophagy, which is a bulk-lysosomal degradation pathway, to mitigate damages and increase the chances of cell survival. Deregulation of autophagy causes upregulation of p62 and the formation of p62-containing aggregates, which are associated with neurodegenerative diseases and cancer. The Nrf2-Keap1 pathway functions as a critical regulator of the cell's defense mechanism against oxidative stress by controlling the expression of many cellular protective proteins. Under basal conditions, Nrf2 is ubiquitinated by the Keap1-Cul3-E3 ubiquitin ligase complex and targeted to the 26S proteasome for degradation. Upon induction, the activity of the E3 ubiquitin ligase is inhibited through the modification of cysteine residues in Keap1, resulting in the stabilization and activation of Nrf2. In this current study, we identified the direct interaction between p62 and Keap1 and the residues required for the interaction have been mapped to 349-DPSTGE-354 in p62 and three arginines in the Kelch domain of Keap1. Accumulation of endogenous p62 or ectopic expression of p62 sequesters Keap1 into aggregates, resulting in the inhibition of Keap1-mediated Nrf2 ubiquitination and its subsequent degradation by the proteasome. In contrast, overexpression of mutated p62, which loses its ability to interact with Keap1, had no effect on Nrf2 stability, demonstrating that p62-mediated Nrf2 upregulation is Keap1 dependent. These findings demonstrate that autophagy deficiency activates the Nrf2 pathway in a noncanonical cysteine-independent mechanism.

Citing Articles

Thirty years of NRF2: advances and therapeutic challenges.

Zhang D Nat Rev Drug Discov. 2025; .

PMID: 40038406 DOI: 10.1038/s41573-025-01145-0.


Molecular mechanisms of autophagy and implications in liver diseases.

Wu Y, Tan H, Lin J, Shen H, Wang H, Lu G Liver Res. 2025; 7(1):56-70.

PMID: 39959698 PMC: 11792062. DOI: 10.1016/j.livres.2023.02.002.


p62/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair.

Yang X, Cao X, Zhu Q Cancer Metastasis Rev. 2025; 44(1):33.

PMID: 39954143 PMC: 11829845. DOI: 10.1007/s10555-025-10250-w.


Reinforcing Nrf2 Signaling: Help in the Alzheimer's Disease Context.

la Torre A, Lo Vecchio F, Angelillis V, Gravina C, DOnofrio G, Greco A Int J Mol Sci. 2025; 26(3).

PMID: 39940900 PMC: 11818887. DOI: 10.3390/ijms26031130.


4-Hydroxy-2-nonenal causes nuclear accumulation of p62 by inhibiting Xpo1 and promoting the proteolytic pathway in the nucleus.

Kayama E, Baoshuo N, Tatsuno R, Nishi K, Mohammed E, Abiko Y PLoS One. 2025; 20(2):e0316558.

PMID: 39899539 PMC: 11790078. DOI: 10.1371/journal.pone.0316558.


References
1.
Zhang D, Lo S, Cross J, Templeton D, Hannink M . Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol. 2004; 24(24):10941-53. PMC: 533977. DOI: 10.1128/MCB.24.24.10941-10953.2004. View

2.
Komatsu M, Waguri S, Koike M, Sou Y, Ueno T, Hara T . Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007; 131(6):1149-63. DOI: 10.1016/j.cell.2007.10.035. View

3.
Tong K, Katoh Y, Kusunoki H, Itoh K, Tanaka T, Yamamoto M . Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol. 2006; 26(8):2887-900. PMC: 1446969. DOI: 10.1128/MCB.26.8.2887-2900.2006. View

4.
Moinova H, Mulcahy R . Up-regulation of the human gamma-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element. Biochem Biophys Res Commun. 1999; 261(3):661-8. DOI: 10.1006/bbrc.1999.1109. View

5.
Yue Z, Jin S, Yang C, Levine A, Heintz N . Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003; 100(25):15077-82. PMC: 299911. DOI: 10.1073/pnas.2436255100. View